In 2013, Bethany Bray was frustrated by lengthy phase I-IV clinical trial patient recruitment times and expensive patient recruitment strategies in her work in Neuroscience Research at Imperial College London and Oncology Research at the Winship Cancer Institute of Emory University. Collaborating with Chris Klaus and Ben Cooper, the trio devised a web-based software platform that allows patients or healthy volunteers to be recruited for any clinical trial, in any disease area, in any location, across the globe.
Originally formed in 2014 as NeuroCruitment with a sole focus on neurological conditions, the benefits and effectiveness of the company’s unique web-based software platform quickly attracted CROs, sponsors and research sites addressing other therapeutic areas. The company changed its name in early 2015 to AutoCruitment and expanded its offering, referring patients for clinical trials in all therapeutic areas.
By streamlining the recruitment process, AutoCruitment helps accelerate the commercialization of safe, effective new treatments for devastating diseases and conditions. Clients are not the only ones to benefit from expediting the recruiting process; the platform empowers people who are suffering from chronic illness or diseases with the ability to locate and enroll in applicable clinical trials that offer access to potential medical advances.
AutoCruitment is headquartered at Technology Square in Atlanta, GA with offices in New York, NY and Toronto, ON.
Our story starts in 2013 but doesn’t end there. As the need to bring pharmaceuticals and treatments to the market continues, so does the need for AutoCruitment to evolve and expand. We continually update our algorithms and advance our technology to meet the needs of the industry
Partners Bethany Bray, Chris Klaus and Ben Cooper create a web-based software platform that recruits and matches patients to clinical trials, focusing on neurological conditions. They call this platform and newly found algorithm NeuroCruitment.
NeuroCruitment is Incorporated as the platform quickly begins to gain the attention of CROs, Sponsors and Research Sites. NeuroCruitment is accepted into ATDC, one of the nation’s premier technology startup incubators.
Click Here
NeuroCruitment open’s an office in Technology Square, Atlanta GA and graduates from the NeuroLaunch Accelerator. Partnering with one of the world’s largest CRO’s, NeuroCruitment expands into all therapeutic areas, changing their name to AutoCruitment.
AutoCruitment continues to bring on Sponsor and CRO Partner Clients and accepts an investment from a strategic industry leader further strengthening their mission to reduce pharmaceutical companies’ risk of clinical trials failing due to patient enrollment.
AutoCruitment opens a second office in New York, NY to assist in serving their Sponsor and CRO Partner Clients. AutoCruitment expands into Europe, South America and ROW, targeting patients using over 1,500 digital channels to target, recruit, qualify and refer prospective patients in real time.
AutoCruitment launches their Site and Patient Engagement Offering, streamlining the process of patient recruitment and ensuring a focus on randomization and retention. AutoCruitment completes their 300th clinical trial.
AutoCruitment opens a third office in Toronto, ON expanding their Technology, Operations, Leadership, Digital Marketing, Site Engagement, Patient Engagement and Project Management teams to support the growing patient network and Client base as they continue to develop the AutoCruitment Platform.
AutoCruitment is now partnered with numerous Sponsors, including 4 of the world’s top 10 pharmaceutical companies and 9 of the largest CROs worldwide.
AutoCruitment’s mission is to empower patients by giving them access to an automated platform that will match them to a clinical trial, accelerating the commercialization of safe, effective new treatments for devastating conditions and diseases.
AutoCruitment endeavors to completely remove the patient recruitment barrier from clinical research; decreasing the cost and time it takes to get therapies to market.
By streamlining the patient recruitment process, AutoCruitment helps accelerate the commercialization of safe, effective new treatments for conditions in all therapeutic areas with a continual commitment to optimization and excellence.
The AutoCruitment platform empowers and enables those who are suffering from various conditions and chronic illnesses with the ability to locate and access clinical trials and potentially life-saving new treatments in a safe and approachable environment.
Bethany Bray, founder of AutoCruitment, has a strong scientific background, giving her unique insight into the requirements of companies conducting clinical trials. In her role as CEO, Bethany leads strategic client relationships for AutoCruitment and is a recognized thought leader in the Pharmaceutical Industry. Bethany brings over a decade of expertise optimizing AutoCruitment’s proprietary technology platform and algorithms to accelerate online patient recruitment for clinical trials while decreasing recruitment timelines to patient randomization. Bethany holds a BSc in Pharmacology, a Masters in Translational Medicine and Neuroscience from Imperial College London, UK, and an MBA from the Georgia Institute of Technology, US, with a concentration in entrepreneurship and technology innovation. Bethany was hand selected into the elite TI:GER (Technology Innovation: Generating Economic Results) program while serving as an oncology research specialist at the Winship Cancer Institute of Emory University Hospital prior to founding AutoCruitment.
Ben Cooper has started and co-founded two companies (both of which remain in operation), advised Porsche AG, Europe and North America and the Volkswagen group on IT Strategy and Innovation, led high growth companies as a Sales and Strategy executive and advised over 150 companies (including Prestige Cruise Holdings, Blue Cross Blue Shield Association, The Gerber Group, National Corporate and Government Law Firm Jackson Kelly PLLC) on Sales and IT Strategy.
Ben received his BSc in Biochemistry from Florida Atlantic University and has extensive international corporate relationships with many Fortune 100 Companies within the USA, Europe and the Asia Pacific.
Chris Klaus was the founder and CTO of Internet Security Systems (ISS), which was acquired by IBM for $1.3B. Chris formed ISS in the early 1990s as a student at the Georgia Institute of Technology. He grew the company to 1,200 employees and took the company public. He is currently founder and CEO of Kaneva, the first company to integrate social networking, shared media, games and collaborative communities into an immersive 3D virtual world.
AutoCruitment is proud to be a member of Georgia Tech's elite ATDC Select Technology Group as
well as a graduate of the NeuroLaunch Accelerator.
“A diverse team of marketing, clinical trial, operations and technology specialists with two things in common, a unique passion for our Patients and Clients and an unmatched determination to get the job done.”
“An amazing technology, online platform and brand that resonates with patients, assisting them in finding Clinical Trials and providing them with access to alternative treatments.”
“AutoCruitment has an inspiring team that’s always ready to jump in and collaborate to solve whatever new tasks come up. We embrace new technologies and optimization as a way to continuously improve and I couldn’t ask for more.”
“To me, AutoCruitment is about uniting our clients’ goals, site feedback, and campaign data to find candidates best suited to the study as a whole. Having managed a clinical research site in the past, I understand the feeling of achievement that comes with finding the right patient. It’s exciting to see our solution working across so many indications– I still celebrate the first randomization on every campaign!"
“For me AutoCruitment is about using the latest technology, analytics, and optimization to reach our targeting audience to inform them about new trials that could benefit their everyday lives.”
“AutoCruitment bridges the gap between patients and people who need care, and the companies that are capable of helping these people. To me, AutoCruitment is the ability to speak to and be heard by both parties; to create a symbiotic relationship that benefits everyone. AutoCruitment means fast, safe, reliable, technological and methodical.”
AutoCruitment streamlines the recruitment process and helps accelerate the commercialization of safe, effective treatments for conditions in all therapeutic areas. Using more than 1,500 digital channels, AutoCruitment is an industry leader in clinical trial patient recruitment, offering online recruitment services and use of the web-based AutoCruitment Platform globally.
AutoCruitment was founded in 2014 by Bethany Bray, MBA MRes (Imperial College London), Ben Cooper and Chris Klaus (founder of Internet Security Systems; now part of the IBM Group). The leading, web-based recruitment company is headquartered in Technology Square, Atlanta GA with Project Management and Operations located in New York, NY and Toronto, ON.
AutoCruitment has assisted in the recruitment and automated screening of patients for all therapeutic areas and is currently working with 4 of the top 10 pharmaceutical companies, 9 of the largest CROs worldwide, numerous hospitals and research sites to reduce the time it takes to get lifesaving therapies to market; through the use of their platform which recruits and matches qualified patients to the correct trials and clinical programs, automatically.
AutoCruitment’s targeted, metrics-driven approach and web-based technology closes the enrollment gap and accelerates patient recruitment by an average of 72%.
